Vaping among Malaysian school adolescents surged from 9.8% in 2017 to 14.9% in 2022, with nicotine and harmful chemicals posing serious health risks including lung injury and cardiovascular effects. Vape products in Malaysia have been adulterated with illicit drugs like ecstasy and synthetic cannabis, creating unpredictable dangers beyond nicotine dependence for unsuspecting users.
Malaysia's Guide to Quitting Vaping: Medical Support and Practical Steps
Misleading product names can conceal serious dangers beyond nicotine dependence.
Why does Malaysia's vaping rate among teenagers matter so much? It's just a trend, isn't it?
The numbers suggest it's more than a trend. We went from roughly one in ten adolescents vaping in 2017 to nearly one in seven by 2022. That's a significant shift in a short time, and it's happening during a critical window for brain development.
But we should be careful here—those figures come from the National Health and Morbidity Survey. It's solid data, but it's a snapshot. We don't know if the rate has continued climbing since 2022 or if it's plateaued.
What makes vaping so appealing to young people if it's actually dangerous?
The marketing is sophisticated. Flavored liquids, sleek devices, social media presence—it all creates an impression of safety and style. The perception that e-cigarettes are "safer" than smoking is widespread, even though that's not the full picture.
That's fair, but we should note that the perception isn't entirely baseless. Vaping does avoid combustion and some of the worst byproducts of burning tobacco. The issue is that it's not harmless, and that nuance gets lost.
You mentioned vape products being adulterated with drugs. How common is that?
In January 2026, Malaysian media reported that seized vape products—some marketed as "magic mushroom"—contained ecstasy and synthetic cannabis. It's a real concern, but we're talking about seized products, which means we don't have a clear picture of how widespread this is in the market.
Exactly. We know it's happening, but we don't know the scale. Is this a widespread problem or isolated cases? The reporting doesn't tell us, and that's an important gap.
So if someone wants to quit, what's actually available to them?
Malaysia has built a fairly comprehensive system. MOH facilities offer assessment, counseling and nicotine replacement therapy. Private clinics and pharmacies participate through mQuit. There's also a digital option through JomQuit and Cik Era AI for people who want to start online.
The infrastructure exists, but access is another question. We know services are available at "participating" facilities, but we don't know how many facilities participate or how long wait times are. The article doesn't tell us whether someone in a rural area can actually access these services.
What's the success rate?
The article doesn't provide one, which is telling. It emphasizes that quitting often takes multiple attempts and that relapse is part of the process, not failure. That's honest framing.
It is, but it also means we don't have concrete data on how many people actually achieve lasting cessation through these programs. That would be useful information for someone deciding whether to seek help.
Le Pouls
- Vaping among Malaysian school adolescents aged 13-17 increased from 9.8% in 2017 to 14.9% in 2022
- Seized vape products in Malaysia in January 2026 contained ecstasy and synthetic cannabis mimics
- Vape aerosols contain formaldehyde, acrolein, nickel and lead
- Nicotine replacement therapy, counseling and follow-up support available through MOH facilities, private clinics and mQuit program
Vaping among Malaysian school adolescents surged from 9.8% in 2017 to 14.9% in 2022, with nicotine and harmful chemicals posing serious health risks including lung injury and cardiovascular effects. Vape products in Malaysia have been adulterated with illicit drugs like ecstasy and synthetic cannabis, creating unpredictable dangers beyond nicotine dependence for unsuspecting users.
Malaysia addresses rising vaping use among adolescents with structured cessation support, highlighting nicotine dependence risks and available medical treatments including counselling and nicotine replacement therapy.
Vaping has become a fixture in Malaysian life, particularly among teenagers and young adults drawn to flavored liquids, sleek devices and the social media narrative that e-cigarettes are a safer alternative to smoking. The numbers tell the story: between 2017 and 2022, current vape use among school-going adolescents aged 13 to 17 nearly doubled, climbing from 9.8 percent to 14.9 percent. What many users don't realize is that most vape liquids contain nicotine, one of the most addictive substances available, and that repeated exposure during adolescence can interfere with brain development in ways that affect attention, learning and impulse control.
The health picture extends far beyond nicotine dependence. Researchers have identified formaldehyde, acrolein and heavy metals including nickel and lead in vape aerosols. These chemicals irritate the lungs and trigger inflammation. While long-term effects are still being studied, vaping has been linked to chronic cough, shortness of breath and wheezing. Nicotine itself raises heart rate and blood pressure, adding cardiovascular concerns to the respiratory ones. In severe cases, users develop e-cigarette or vaping product use-associated lung injury, or EVALI, a condition involving lung inflammation and damage that can deteriorate lung function, lower blood oxygen levels and require hospitalization, oxygen therapy or breathing support. Patients may experience chest pain, fever, nausea or vomiting.
A darker risk emerged in January 2026 when Malaysian media reported that analyses of seized vape products—some marketed under names like "magic mushroom"—contained ecstasy and synthetic substances designed to mimic cannabis. These adulterants affect brain function, altering perception, mood and behavior while impairing judgment and coordination. Because users often don't know what substances or doses they're inhaling, the effects are unpredictable. Misleading product names can conceal serious dangers that go well beyond nicotine addiction.
The harm extends to people who don't vape. While vaping is often presented as less harmful to bystanders than cigarette smoke, secondhand exposure to vape aerosol carries real risk. The aerosol contains fine particles, nicotine and potentially harmful chemicals that people nearby inhale. Indoors, nicotine and other chemical residues settle on surfaces, creating what researchers call "thirdhand exposure" through contact with contaminated dust and materials. Children, pregnant women and people with asthma face particular vulnerability. Beyond the physical risks, vaping at home normalizes nicotine use for children and adolescents, potentially encouraging them to experiment. Some users attempt to quit smoking by switching to vaping but end up using both products—a pattern called "dual use" that exposes them to harmful substances from both cigarette smoke and vape aerosol without providing genuine health protection.
Malaysia's healthcare system has responded by expanding cessation services to address nicotine dependence regardless of delivery method. Quit-smoking support is available at participating Ministry of Health hospitals and clinics, where staff assess dependence, provide counseling, recommend treatment and offer follow-up care. Appointments can be booked through MySejahtera. For those seeking services outside MOH facilities, selected private clinics and community pharmacies offer cessation programs through the mQuit initiative. The JomQuit website helps people locate participating providers and access digital guidance through Cik Era AI.
Healthcare professionals typically recommend nicotine replacement therapy, or NRT, which delivers controlled amounts of nicotine to reduce cravings and withdrawal symptoms without exposure to smoke or aerosol. Nicotine patches release the substance steadily, while faster-acting products like gum or mouth sprays address cravings as they occur. Pharmacists play a crucial role as accessible front-line providers, helping individuals select appropriate NRT products and doses, explaining correct usage techniques and advising on side effects. Incorrect use can undermine treatment effectiveness, making this guidance essential. Alongside medication, doctors, pharmacists and trained counselors provide behavioral support to help people identify triggers, develop coping strategies and stay motivated. Follow-up appointments allow progress to be monitored and treatment adjusted as needed.
For someone ready to quit, a practical plan transforms intention into action. This includes setting a quit date, identifying situations that trigger use and preparing strategies to manage cravings. Removing cigarettes, vaping devices and related supplies from the immediate environment reduces reminders and temptation. Family and friends can help by offering encouragement and avoiding smoking or vaping around the person attempting to quit. Most people don't succeed on the first try, and that's understood as part of the process. A lapse provides information about what made stopping difficult and an opportunity to adjust the plan with professional guidance. Continued counseling, appropriate treatment and follow-up support can help individuals achieve lasting cessation. Those who have already quit smoking should avoid returning to cigarettes while seeking help to stop vaping. With the right treatment and sustained support, stopping is achievable, even when multiple attempts are needed.
Citations marquantes
Nicotine withdrawal may cause cravings, irritability, restlessness and difficulty concentrating, making support essential for successful cessation.— Malaysia's healthcare system guidance on quit-smoking services
A lapse does not mean that the effort has failed; it provides an opportunity to identify what made stopping difficult and review the quit plan with a healthcare professional.— Cessation guidance for individuals attempting to quit